Tag Archives: oracle argus safety migration

Oracle AERS vs. Argus Safety

Posted by lifescienceswebinars in Uncategorized and tagged with , , , , , , , ,

Not too long ago, Oracle AERS was the most widely-used adverse event report system. However, with the acquisition of Relsys and its safety and pharmacovigilance system in 2009, Argus Safety quickly became the go-to software for most life sciences companies. Its capabilities and comprehensiveness are unmatched.

Companies currently using Oracle AERS have expressed interest in moving to Argus Safety, but want to know more before making the jump. This webinar is meant to do just that – answer your common questions.

Please join Perficient’s Dr. Rodney Lemery, director of safety and pharmacovigilance, for a free one-hour webinar in which he will:

  • Compare Argus Safety to AERS
  • Cover the options of effectively migrating to Argus Safety

Register: https://cc.readytalk.com/cc/s/registrations/new?cid=797ko39igeyx

MIGRATING FROM ORACLE AERS TO ARGUS SAFETY: THE REASONS FOR THE MOVE

Posted by lifescienceswebinars in adverse event reporting system, aers to argus, Argus Safety, Argus Safety Database, argus safety integration, argus safety interchange e2b, argus safety japan, argus safety migration, Argus Safety Suite, Clinical Trial Data Regulatory Submissions, Drug Safety, drug safety software, oracle aers, Oracle Argus, Oracle Argus Safety, oracle argus safety japan, Pharmacovigilance, Pharmacovigilance software, Pharmacovigilance System and tagged with , , , , , , , , ,

by Eugene Sefanov

Not too long ago, Oracle AERS was the most widely-used adverse event report system. However, with the acquisition of Relsys and its safety and pharmacovigilance system in 2009, Argus Safety quickly became the go-to software for most life sciences companies. Its capabilities and comprehensiveness simply were, and continues to be, unmatched.

Companies currently using Oracle AERS have expressed interest in moving to Argus Safety, but want to know more before making the jump. This webinar is meant to do just that – answer your common questions.

Please join BioPharm’s Dr. Rodney Lemery, VP of safety and pharmacovigilance, for a free one-hour webinar in which he will:

  • Compare Argus Safety to AERS
  • Cover the options of effectively migrating to Argus Safety

Register to view the webinar: https://cc.readytalk.com/r/797ko39igeyx&eom

For more information about BioPharm Systems, please visit www.biopharm.com.

MIGRATING FROM EMPIRICA TRACE TO ARGUS SAFETY: THE REASONS FOR THE MOVE

Posted by lifescienceswebinars in Argus, argus interchange, argus j, argus japan, Argus Safety, Argus Safety Database, argus safety integration, argus safety interchange e2b, argus safety japan, Argus Safety Suite, Clinical Trial Data Regulatory Submissions, Drug Safety, Drug Safety Database, drug safety software, Drug Safety System, Oracle Argus, Oracle Empirica, Pharmacovigilance, Pharmacovigilance software, Pharmacovigilance System and tagged with , , , , , , , , , , , ,

by Eugene Sefanov

Oracle added Empirica Trace to its product portfolio when it acquired Phase Forward in 2010. Although the safety database has successfully helped organizations meet their requirements over the years, it lacks many user-friendly features and the deep functionality that is essential in today’s highly-regulated environment. Whether the capabilities relate to system management, coding, E2B, languages, or reporting, there are many differentiators in Argus Safety that current Empirca Trace users will be able to appreciate.

Please join BioPharm’s Dr. Rodney Lemery, VP of safety and pharmacovigilance, for a free one-hour webinar in which he will:

  • Compare Argus Safety to Empirica Trace
  • Cover the options of effectively migrating to Argus Safety

Register to view the webinar: https://cc.readytalk.com/r/73vghet75yx8&eom

For more information about BioPharm Systems, please visit www.biopharm.com.